
Antibody responses to SARS-CoV-2 in patients with COVID-19 from Nature.com

Abstract
We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG). Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Serological testing may be helpful for the diagnosis of suspected patients with negative RT–PCR results and for the identification of asymptomatic infections.
Main
The continued spread of coronavirus disease 2019 (COVID-19) has prompted widespread concern around the world, and the World Health Organization (WHO), on 11 March 2020, declared COVID-19 a pandemic. Studies on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) showed that virus-specific antibodies were detectable in 80–100% of patients at 2 weeks after symptom onset1,2,3,4,5,6. Currently, the antibody responses against SARS-CoV-2 remain poorly understood and the clinical utility of serological testing is unclear7.
Full Article Click here
You Might Also Enjoy...


Do you have a question about your COVID-19 Screening ?

The Testing Debate for COVID-19: PCR vs. Rapid Antibody Test (Paper)

The Need of Private Sector for Taking the Lead in Defeating COVID19 in the US.
GoodRx, Sanofi to offer insulin for $35, regardless of insurance, at select pharmacies
